Description
+ Include: 22 Videos (.mp4) + 22 Subtitles (.vtt) + 23 PDFs, size: 3.08 GB
+ Target Audience: psychiatrists and mental health clinicians
+ Sample video: contact me for sample video
+ Information:
1. Overview
The presentation places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes.
The seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.
Course Date: February 16-20, 2026
2. Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe the historical background on the major themes to be covered during the course.
- Examine the biological mechanisms of major psychotropic drug classes.
- Grasp the basic neuroanatomy relevant to clinical psychopharmacology.
- Recognize and apply key clinical trials of drug classes for various diagnoses.
- Examine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment.
- Discuss practices with antipsychotics, mood stabilizers, and antidepressants.
- Explain the risks and side effects of major drug classes.
- Employ medications with an understanding of pharmacokinetic interactions.
- Identify factors in medication use for those with comorbid medical conditions.
3. Target Audience
Best for psychiatrists and mental health clinicians who want updates on psychopharmacology, drug safety, and mood disorder management.
4. Topics
-
01 Bipolar Depression and Mixed States – Why Antidepressants Fail and Dopamine Blockers Work
-
02 Mood Stabilizers in Bipolar Disorder – Limitations of Anticonvulsants vs Lithium
-
03 How Mood Temperaments Drive Misdiagnosis in Psychiatry
-
04 Treating Mood Temperaments to Improve Mental Health Outcomes
-
05 Antipsychotic Safety – Neurotoxicity, Akathisia, and Tardive Dyskinesia Risks
-
06 Lithium in Mood Disorders – Is It the Safest Mood Stabilizer
-
07 Lithium Safety and Renal Effects – Interpreting eGFR and True Kidney Risk
-
08 Antipsychotics in Schizophrenia – Short-Term Symptom Control vs Long-Term Outcomes
-
09 Antipsychotic-Induced Akathisia and EPS – Clinical Risks and Management
-
10 Antipsychotics and Metabolic Risk – Insulin Resistance, Weight Gain, & More
-
11 Bipolar Mania Management With Antipsychotics – Acute Efficacy vs Maintenance Limitations
-
12 ADHD – Clinical Efficacy and Safety of Amphetamine-Based Therapies
-
13 Antidepressant Safety Risks – Suicidality, Cardiovascular Effects, and Withdrawal Syndromes
-
14 MDD Maintenance Treatment – Do Antidepressants Sustain Remission
-
15 Acute Treatment of Major Depressive Disorder – Interpreting Effect Size, Placebo Response, and Clinical Meaningfulness
-
16 Do Antidepressants Work in Bipolar Depression or Worsen Outcomes
-
17 Basic Concepts of Psychopharmacology for the Clinician
-
18 Neurobiology in Psychopharmacology – Why Mechanisms Matter Less Than Clinical Outcomes
-
19 Antipsychotic Psychopharmacology – Receptor Affinity, Dosing, and Adverse Effects
-
20 Mood Stabilizer Neurobiology – Lithium and Antiepileptics Mechanisms
-
21 Psychopharmacology of Monoamine Agonists From Chemical Structure to Clinical Effect
-
22 Benzodiazepines & Alternatives for Sleep and Anxiety Disorders – Pharmacology & Adverse Effects
Reviews
There are no reviews yet.